Share Email Print

Proceedings Paper

New applications of fluorescence polarization for enzyme assays and in genomics
Author(s): Theo Nikiforov; Jill Coffin; Sang Jeong; Anton Simeonov; Xiahui Bi
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

We have developed new, fluorescence polarization-based approaches for performing enzyme assays in homogeneous solutions and for detecting the hybridization of peptide nucleic acids to DNA targets. In the first method, fluorescein-labeled peptides serving as protein kinase sustrates are thiophosphorylated in the presence of the ATP analog ATPγS. A sulfer-reactive biotin derivative is then added to the mixture and allowed to react with the thiophosphorylated peptide. The formation of a fluorescein-labeled, biotinylated product can be detected by measuring the fluorescence polarization signal of fluorescein upon addition of streptavidin. In the second method, fluorescein-labeled peptides are subjected to enzymatic phosphorylation, desphosphorlation, or proteollytic cleavage by protein kinases, phosphatases, and proteases. The differential binding of the enzymatic substrates and products to cationic polymers such as polyaraginine can be conveniently measured by fluorescence polarization. Finally, we have discovered that the process of hybridization of peptide nucleic acid probes (PNAs) to their target DNA molecules can be followed by measuring the fluorescence polarization of a fluorophore attached to the PNA probes. These measurements can be done either in the presence or absence of polylysine in solution. Examples of the application of this method for single nucleotide polymorphism (SNP) typing are presented.

Paper Details

Date Published: 22 May 2001
PDF: 12 pages
Proc. SPIE 4255, Clinical Diagnostic Systems, (22 May 2001); doi: 10.1117/12.426750
Show Author Affiliations
Theo Nikiforov, Caliper Technologies Corp. (United States)
Jill Coffin, Caliper Technologies Corp. (United States)
Sang Jeong, Caliper Technologies Corp. (United States)
Anton Simeonov, Caliper Technologies Corp. (United States)
Xiahui Bi, Caliper Technologies Corp. (United States)

Published in SPIE Proceedings Vol. 4255:
Clinical Diagnostic Systems
Gerald E. Cohn, Editor(s)

© SPIE. Terms of Use
Back to Top